Rockwell Medical price target lowered to $2.50 from $3 at H.C. Wainwright

H.C. Wainwright lowered the firm’s price target on Rockwell Medical (RMTI) to $2.50 from $3 and keeps a Buy rating on the shares after the company reported a “slight” top-line miss in Q3. The firm, which has adjusted its long-term forecasts, tells investors that the company’s revenue base, while “meaningfully more diversified” than in the past, may not benefit from large contracts as much as in the past.